Correlation Between Redhill Biopharma and Organogenesis Holdings
Can any of the company-specific risk be diversified away by investing in both Redhill Biopharma and Organogenesis Holdings at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Redhill Biopharma and Organogenesis Holdings into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Redhill Biopharma and Organogenesis Holdings, you can compare the effects of market volatilities on Redhill Biopharma and Organogenesis Holdings and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Redhill Biopharma with a short position of Organogenesis Holdings. Check out your portfolio center. Please also check ongoing floating volatility patterns of Redhill Biopharma and Organogenesis Holdings.
Diversification Opportunities for Redhill Biopharma and Organogenesis Holdings
-0.7 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Redhill and Organogenesis is -0.7. Overlapping area represents the amount of risk that can be diversified away by holding Redhill Biopharma and Organogenesis Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Organogenesis Holdings and Redhill Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Redhill Biopharma are associated (or correlated) with Organogenesis Holdings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Organogenesis Holdings has no effect on the direction of Redhill Biopharma i.e., Redhill Biopharma and Organogenesis Holdings go up and down completely randomly.
Pair Corralation between Redhill Biopharma and Organogenesis Holdings
Given the investment horizon of 90 days Redhill Biopharma is expected to under-perform the Organogenesis Holdings. In addition to that, Redhill Biopharma is 1.85 times more volatile than Organogenesis Holdings. It trades about -0.05 of its total potential returns per unit of risk. Organogenesis Holdings is currently generating about 0.06 per unit of volatility. If you would invest 262.00 in Organogenesis Holdings on August 24, 2024 and sell it today you would earn a total of 140.00 from holding Organogenesis Holdings or generate 53.44% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Redhill Biopharma vs. Organogenesis Holdings
Performance |
Timeline |
Redhill Biopharma |
Organogenesis Holdings |
Redhill Biopharma and Organogenesis Holdings Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Redhill Biopharma and Organogenesis Holdings
The main advantage of trading using opposite Redhill Biopharma and Organogenesis Holdings positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Redhill Biopharma position performs unexpectedly, Organogenesis Holdings can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Organogenesis Holdings will offset losses from the drop in Organogenesis Holdings' long position.Redhill Biopharma vs. Organogenesis Holdings | Redhill Biopharma vs. Lifecore Biomedical | Redhill Biopharma vs. Collegium Pharmaceutical | Redhill Biopharma vs. Aquestive Therapeutics |
Organogenesis Holdings vs. Shuttle Pharmaceuticals | Organogenesis Holdings vs. Lifecore Biomedical | Organogenesis Holdings vs. Redhill Biopharma | Organogenesis Holdings vs. Collegium Pharmaceutical |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |